好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Reversible Cerebral Vasoconstriction Syndrome: Report of a Case Treated Successfully with Intra-Arterial Milrinone
Headache/Other Pain Syndromes
(-)
025
Authors/Disclosures
Manon Bouchard, MD (Clinique Neuro Levis) Dr. Bouchard has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Bouchard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Bouchard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Es Therapeutics. Dr. Bouchard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Bouchard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Bouchard has received research support from FRQS. Dr. Bouchard has received publishing royalties from a publication relating to health care.
Steve Verreault, MD (Hopital De L'Enfant-Jesus) The institution of Dr. Verreault has received research support from BMS. The institution of Dr. Verreault has received research support from Portola. The institution of Dr. Verreault has received research support from Daichii Sankyo.
No disclosure on file
Nicolas Dupre, MD, FAAN (CHU de Quebec - U Laval) Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Anne S. Lindblad, PhD No disclosure on file
No disclosure on file